搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
Opinion
7 小时
on MSN
Opinion
Trump just showed RFK Jr.’s supporters there’s no space at the table for them — literally
Donald Trump and Robert F. Kennedy Jr. hosted the chief executives of Pfizer, Eli Lilly and PhRMA for dinner at Mar-a-Lago.
Irish Examiner
8 小时
'You still have to work with it': Campaigner warns weight loss drugs are not a 'quick-fix ...
Irish Coalition for People Living with Obesity's Susie Birney did say however, that many people in Ireland have seen their ...
10 小时
on MSN
BofA restarts coverage of 11 large-cap biopharmas
BofA has reinstated coverage of 11 large-cap pharmaceutical and biotech stocks, with Eli Lilly (NYSE:LLY), Gilead ...
newsbug
11 小时
Ephraim Stoner named 2025 2025 Lilly Endowment Community Scholarship recipient
The Warren County Community Foundation is pleased to announce the recipient of the 2025 Lilly Endowment Community Scholarship ...
Opinion
12 小时
Opinion
Opinion | RFK Jr. is already falling in line with Trump’s corruption
Donald Trump and Robert F. Kennedy Jr. hosted the chief executives of Pfizer, Eli Lilly and PhRMA for dinner at Mar-a-Lago.
Ibj.com
12 小时
Lilly CEO predicts obesity-treatment Zepbound will become drugmaker’s top drug by 2025
David Ricks told a lunch audience at the Economic Club of Washington, D.C., that Zepbound could quickly become the most ...
Ibj.com
12 小时
Lilly to test obesity drugs for addiction treatment, CEO says
The company also raised its quarterly dividend 15% amid rapid growth fueled in part by the blockbuster weight-loss drug ...
12 小时
Lilly CEO says tax and regulation reform, drug affordability are focuses under Trump
Eli Lilly CEO David Ricks on Tuesday said at the Economic Club of Washington that tax and regulation reform and drug ...
BioPharma Dive
14 小时
ASH24: Leukemia drug sequencing, sickle cell questions and a new kind of CAR-T
Data from Eli Lilly and AstraZeneca could help doctors decide treatment order in chronic lymphocytic leukemia. Elsewhere, ...
Finbold | Finance in Bold
16 小时
Jim Cramer reveals the most overlooked stock for 2025
Jim Cramer recently revealed which sector investors are 'complacently' positive about, and which one might be unfairly ...
FiercePharma
16 小时
High-flying Eli Lilly plots $15B share buyback campaign
With Eli Lilly's diabetes and obesity products Mounjaro and Zepbound booming in popularity, the drugmaker finds itself in a ...
24/7 Wall St
17 小时
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈